Filing Flows › Phibro Animal Health (PAHC) › Q4 FY26 › vs Q4 FY25
Phibro Animal Health (PAHC) Q4 FY26 vs Q4 FY25 (year over year)
Phibro Animal Health's revenue rose $18.1M (+5%) from $379M in Q4 FY25 to $397M in Q4 FY26. Gross margin 33.9% against 29.0% (+4.8 pts).
Phibro Animal Health, Q4 FY26: revenue $397M (+5% year over year), operating margin 12.1%, net earnings $21.7M, operating cash flow $24.1M. The chart draws each line against Q4 FY25, the increases inside each band.
Margins
| Q4 FY26 | Q4 FY25 | Change | |
|---|---|---|---|
| Gross margin | 33.9% | 29.0% | +4.8 pts |
| Operating margin | 12.1% | 8.9% | +3.2 pts |
| Net margin | 5.5% | 4.5% | +0.9 pts |
| Free cash flow margin | 1.3% | 2.1% | -0.8 pts |
Every line
| Line | Q4 FY26 | Q4 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $397M | $379M | $18.1M | +5% |
| Gross profit | $134M | $110M | $24.4M | +22% |
| Cost of revenue | $262M | $269M | −$6.3M | -2% |
| Operating profit | $48.2M | $33.7M | $14.4M | +43% |
| Operating expenses | $86.2M | $76.3M | $10.0M | +13% |
| Pre-tax earnings | $32.3M | $23.8M | $8.5M | +36% |
| Other expense, net | $15.8M | $9.9M | $5.9M | +60% |
| Net earnings | $21.7M | $17.2M | $4.5M | +26% |
| Income tax | $10.6M | $6.6M | $4.0M | +61% |
| Depreciation & amortization | $13.3M | $12.4M | $934K | +8% |
| Share-based compensation | $413K | $179K | $234K | +131% |
| Working capital & other | $11.4M | $8.5M | $2.8M | +33% |
| Operating cash flow | $24.1M | $21.3M | $2.8M | +13% |
| Free cash flow (OCF − capex) | $5.2M | $8.1M | −$2.9M | -36% |
| Capital expenditures | $18.9M | $13.1M | $5.7M | +44% |
Questions
How much did Phibro Animal Health's revenue grow year over year in Q4 FY26?
Phibro Animal Health's revenue rose $18.1M (+5%) from $379M in Q4 FY25 to $397M in Q4 FY26. Gross margin 33.9% against 29.0% (+4.8 pts).